These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 16918686)

  • 1. Pax5--a critical inhibitor of plasma cell fate.
    Nera KP; Lassila O
    Scand J Immunol; 2006 Sep; 64(3):190-9. PubMed ID: 16918686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of Pax5 promotes plasma cell differentiation.
    Nera KP; Kohonen P; Narvi E; Peippo A; Mustonen L; Terho P; Koskela K; Buerstedde JM; Lassila O
    Immunity; 2006 Mar; 24(3):283-93. PubMed ID: 16546097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paired box gene 5 isoforms A and B have different functions in transcriptional regulation of B cell development-related genes in immature B cells.
    Kikuchi H; Nakayama M; Kuribayashi F; Mimuro H; Imajoh-Ohmi S; Nishitoh H; Takami Y; Nakayama T
    Microbiol Immunol; 2015 Jul; 59(7):426-31. PubMed ID: 26094714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pax5 maintains cellular identity by repressing gene expression throughout B cell differentiation.
    Carotta S; Holmes ML; Pridans C; Nutt SL
    Cell Cycle; 2006 Nov; 5(21):2452-6. PubMed ID: 17102626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene repression by Pax5 in B cells is essential for blood cell homeostasis and is reversed in plasma cells.
    Delogu A; Schebesta A; Sun Q; Aschenbrenner K; Perlot T; Busslinger M
    Immunity; 2006 Mar; 24(3):269-81. PubMed ID: 16546096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Losing B cell identity.
    Carotta S; Nutt SL
    Bioessays; 2008 Mar; 30(3):203-7. PubMed ID: 18293359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunologic regulation of bone development.
    Horowitz MC; Lorenzo JA
    Adv Exp Med Biol; 2007; 602():47-56. PubMed ID: 17966387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initiation of plasma-cell differentiation is independent of the transcription factor Blimp-1.
    Kallies A; Hasbold J; Fairfax K; Pridans C; Emslie D; McKenzie BS; Lew AM; Corcoran LM; Hodgkin PD; Tarlinton DM; Nutt SL
    Immunity; 2007 May; 26(5):555-66. PubMed ID: 17509907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversion of B cell commitment upon loss of Pax5 expression.
    Mikkola I; Heavey B; Horcher M; Busslinger M
    Science; 2002 Jul; 297(5578):110-3. PubMed ID: 12098702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential regulation of sense and antisense promoter activity at the Csf1R locus in B cells by the transcription factor PAX5.
    Ingram RM; Valeaux S; Wilson N; Bouhlel MA; Clarke D; Krüger I; Kulu D; Suske G; Philipsen S; Tagoh H; Bonifer C
    Exp Hematol; 2011 Jul; 39(7):730-40.e1-2. PubMed ID: 21549805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shedding B cell identity.
    Singh H; Sciammas R
    Immunity; 2006 Mar; 24(3):239-40. PubMed ID: 16546090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pax5: a master regulator of B cell development and leukemogenesis.
    Medvedovic J; Ebert A; Tagoh H; Busslinger M
    Adv Immunol; 2011; 111():179-206. PubMed ID: 21970955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Hands-on" regulation of B cell development by the transcription factor Pax5.
    Hagman J; Lukin K
    Immunity; 2007 Jul; 27(1):8-10. PubMed ID: 17663980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mechanism of repression of the myeloid-specific c-fms gene by Pax5 during B lineage restriction.
    Tagoh H; Ingram R; Wilson N; Salvagiotto G; Warren AJ; Clarke D; Busslinger M; Bonifer C
    EMBO J; 2006 Mar; 25(5):1070-80. PubMed ID: 16482219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional function of E2A, Ebf1, Pax5, Ikaros and Aiolos analyzed by in vivo acute protein degradation in early B cell development.
    Fedl AS; Tagoh H; Gruenbacher S; Sun Q; Schenk RL; Froussios K; Jaritz M; Busslinger M; Schwickert TA
    Nat Immunol; 2024 Sep; 25(9):1663-1677. PubMed ID: 39179932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined heterozygous loss of Ebf1 and Pax5 allows for T-lineage conversion of B cell progenitors.
    Ungerbäck J; Åhsberg J; Strid T; Somasundaram R; Sigvardsson M
    J Exp Med; 2015 Jun; 212(7):1109-23. PubMed ID: 26056231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcription factor EBF restricts alternative lineage options and promotes B cell fate commitment independently of Pax5.
    Pongubala JM; Northrup DL; Lancki DW; Medina KL; Treiber T; Bertolino E; Thomas M; Grosschedl R; Allman D; Singh H
    Nat Immunol; 2008 Feb; 9(2):203-15. PubMed ID: 18176567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD40 signaling drives B lymphocytes into an intermediate memory-like state, poised between naïve and plasma cells.
    Upadhyay M; Priya GK; Ramesh P; Madhavi MB; Rath S; Bal V; George A; Vaidya T
    J Cell Physiol; 2014 Oct; 229(10):1387-96. PubMed ID: 24482285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcription factor Pax5 activates the chromatin of key genes involved in B cell signaling, adhesion, migration, and immune function.
    Schebesta A; McManus S; Salvagiotto G; Delogu A; Busslinger GA; Busslinger M
    Immunity; 2007 Jul; 27(1):49-63. PubMed ID: 17658281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A critical role of the Thy28-MYH9 axis in B cell-specific expression of the Pax5 gene in chicken B cells.
    Fujita T; Kitaura F; Fujii H
    PLoS One; 2015; 10(1):e0116579. PubMed ID: 25607658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.